Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.
Telix has paid an upfront cost of $230m to acquire 31 licenced radiopharmacies from RLS located across the US.
Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts ...
Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approving ...
UCB has received US FDA approval for BIMZELX (bimekizumab-bkzx) to treat adults with three inflammatory conditions.
The European Commission (EC) has granted marketing authorisation to Leo Pharma ’s Anzupgo (delgocitinib) cream for treating ...
Discover Lyell Immunopharma's groundbreaking patent for EGFR-derived polypeptides, enhancing cancer treatment through innovative nucleic acid technologies and engineered T cells.
Discover Lyra Therapeutics' patented sinus scaffolds for chronic sinusitis treatment, enhancing localized delivery of mometasone furoate for improved patient outcomes.
Discover Laurus Labs' groundbreaking patent for an innovative dapagliflozin synthesis process, enhancing diabetes treatment with novel intermediates and formulations.
Discover Premier Inc.'s groundbreaking patent for stable phytonadione compositions, designed to enhance safety and efficacy while minimizing allergic reactions.
Discover Agile Therapeutics' patented transdermal drug delivery device, designed to reduce skin irritation and enhance stability for effective seven-day wear.